Trial intelligence / Profile preview

Risperidone vs Haloperidol in First Episode Schizophrenia

NCT00157378Phase 4Unknown

Sponsor
Ludwig Maximilian University of Munich
Start
Nov 2000
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of risperidone in schizophrenia, sponsored by Ludwig Maximilian University of Munich. Status: unknown.

02

Drugs

risperidone
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT00157378.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00157378.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call